Vitamin D therapy to reduce cardiovascular risk in Type 2 diabetes – the next steps
- Conditions
- Type 2 diabetes mellitusMedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitus
- Registration Number
- EUCTR2007-003767-51-GB
- Lead Sponsor
- Research and Innovation Services, University of Dundee
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Diagnosis of type 2 diabetes mellitus
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- Taking vitamin D supplements
- Serum 25 hydroxy vitamin D level of >100nmolL
- Serum creatinine >200umol/l
- Liver function tests >3 times the upper limit of normal
- Hyper or hypocalcaemia (corrected calcium >2.55 or <2.15mmol/l, respectively)
- History of sarcoidosis
- History of renal calculi
- Metastatic malignancy
- Inability to give informed consent.
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method